Terms: = Ovarian cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
103 results:
1. Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkers.
Mulugeta A; Lumsden AL; Madakkatel I; Stacey D; Lee SH; Mäenpää J; Oehler MK; Hyppönen E
Cancer Med; 2024 Feb; 13(4):e7051. PubMed ID: 38457211
[TBL] [Abstract] [Full Text] [Related]
2. Mutation analysis of the tert gene in ovarian cancer patients of the Turkish population by next generation sequencing method.
Capar Gorali B; Gulec Yılmaz S; Akdeniz FT; Attar R; İsbir T
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):51-55. PubMed ID: 38015541
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (
Yoo H; Kim HS
Cancer Genomics Proteomics; 2023; 20(6):626-636. PubMed ID: 37889060
[TBL] [Abstract] [Full Text] [Related]
4. Gadolinium-Based Nanoparticles Sensitize ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
Garcia-Prada CD; Carmes L; Atis S; Parach A; Bertolet A; Jarlier M; Poty S; Garcia DS; Shin WG; Du Manoir S; Schuemann J; Tillement O; Lux F; Constanzo J; Pouget JP
J Nucl Med; 2023 Dec; 64(12):1956-1964. PubMed ID: 37857502
[TBL] [Abstract] [Full Text] [Related]
5. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and tert promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
6. ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
Liang Y; Ruan H; Yu M; Lü B
Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
[TBL] [Abstract] [Full Text] [Related]
7. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract] [Full Text] [Related]
8. The Comparative Invasiveness of Endometriotic Cell Lines to Breast and Endometrial cancer Cell Lines.
Ellis K; Wood R
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371583
[TBL] [Abstract] [Full Text] [Related]
9. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
[TBL] [Abstract] [Full Text] [Related]
11. Suppressor-type tert mutations associated with recurrence in ovarian clear cell carcinoma.
Kobayashi T; Nishikimi K; Mitsuhashi A; Piao H; Matsuoka A; Otsuka S; Tate S; Shozu M; Usui H
Genes Chromosomes Cancer; 2023 Aug; 62(8):471-476. PubMed ID: 36710084
[TBL] [Abstract] [Full Text] [Related]
12. Somatic gene mutations in malignant steroid cell tumours and response to multiple treatments.
Nakanishi K; Fukagawa T; Yamada T; Suzuki S
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593625
[TBL] [Abstract] [Full Text] [Related]
13. Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.
Martins FC; Couturier DL; de Santiago I; Sauer CM; Vias M; Angelova M; Sanders D; Piskorz A; Hall J; Hosking K; Amirthanayagam A; Cosulich S; Carnevalli L; Davies B; Watkins TBK; Funingana IG; Bolton H; Haldar K; Latimer J; Baldwin P; Crawford R; Eldridge M; Basu B; Jimenez-Linan M; Mcpherson AW; McGranahan N; Litchfield K; Shah SP; McNeish I; Caldas C; Evan G; Swanton C; Brenton JD
Nat Commun; 2022 Oct; 13(1):6360. PubMed ID: 36289203
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Subclasses of Clear Cell ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.
Bolton KL; Chen D; Corona de la Fuente R; Fu Z; Murali R; Köbel M; Tazi Y; Cunningham JM; Chan ICC; Wiley BJ; Moukarzel LA; Winham SJ; Armasu SM; Lester J; Elishaev E; Laslavic A; Kennedy CJ; Piskorz A; Sekowska M; Brand AH; Chiew YE; Pharoah P; Elias KM; Drapkin R; Churchman M; Gourley C; DeFazio A; Karlan B; Brenton JD; Weigelt B; Anglesio MS; Huntsman D; Gayther S; Konner J; Modugno F; Lawrenson K; Goode EL; Papaemmanuil E
Clin Cancer Res; 2022 Nov; 28(22):4947-4956. PubMed ID: 35816189
[TBL] [Abstract] [Full Text] [Related]
15. Integrated Analysis of ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent tert Rearrangements.
Vougiouklakis T; Zhu K; Vasudevaraja V; Serrano J; Shen G; Linn RL; Feng X; Chiang S; Barroeta JE; Thomas KM; Schwartz LE; Shukla PS; Malpica A; Oliva E; Cotzia P; DeLair DF; Snuderl M; Jour G
Clin Cancer Res; 2022 Apr; 28(8):1724-1733. PubMed ID: 35031544
[TBL] [Abstract] [Full Text] [Related]
16. Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
Dahoud W; Handler J; Parimi V; Meyer CF; Wethington SL; Eshleman JR; Vang R; Ronnett BM; Xing D
Int J Gynecol Pathol; 2022 Nov; 41(6):600-607. PubMed ID: 34856571
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Characterization of Muellerian Tumors of the Urinary Tract.
Ortiz-Brüchle N; Wucherpfennig S; Rose M; Garczyk S; Bertz S; Hartmann A; Reis H; Szarvas T; Kiss A; Bremmer F; Golz R; Knüchel R; Gaisa NT
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200508
[TBL] [Abstract] [Full Text] [Related]
18. FOXL2 and tert promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
[TBL] [Abstract] [Full Text] [Related]
19. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract] [Full Text] [Related]
20. tert Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
[TBL] [Abstract] [Full Text] [Related]
[Next]